期刊文献+

安肺益肾方治疗慢性阻塞性肺疾病稳定期患者疗效观察 被引量:1

Observation on An Fei Yi Shen Formula for Treatment of Patients with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:观察对慢性阻塞性肺疾病(COPD)稳定期的患者行安肺益肾方治疗后的临床疗效及其对生存质量的影响。方法:COPD稳定期50例患者随机分为对照组和观察组,每组25例,对照组行西药信必可和氨茶碱治疗,观察组行中药安肺益肾方治疗。观察治疗后两组的临床疗效,分析不同治疗方法对患者生存质量的影响。结果:对照组的总有效率明显低于观察组(P<0.05);观察组COPD患者在生存质量改善上优于对照组(P<0.05)。结论:安肺益肾方对COPD患者的治疗有显著的疗效,并能明显改善其生存质量。 Objective To observe clinical curative effect of An Fei Yi Shen Formula and its influence on survival treatment in patients with chronic obstructive pulmonary disease.Methods 50 patients were randomly divided into control group and observation group,25 cases in each group,the control line letter will and aminophylline treatment,western medicine group line of traditional Chinese medicine(TCM) Ann lung beneficial kidney treatment.Observe the clinical effects of two groups after the treatment course,the analysis of the effect of different treatment on patients quality of life.ResultsThe total effective rate in the control group was significantly lower than the observation group(P〈0.05);The quality of life in observation group was improved better than that of control group(P〈0.05).Conclusion An Fei Yi Shen Formula for the treatment of patients with chronic obstructive pulmonary disease have significant curative effect,and can significantly improve the quality of life.
出处 《深圳中西医结合杂志》 2016年第6期52-53,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词 慢性阻塞性肺疾病 生存质量 安肺益肾方 Chronic obstructive pulmonary disease quality of life An Fei Yi Shen Formula
  • 相关文献

参考文献5

二级参考文献22

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Peter J Barnes.慢性阻塞性肺疾病的治疗前景[J].中华医学杂志,2006,86(41):2884-2886. 被引量:17
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 4Almagro P,Calbo E,Ochoa de Echagüen A,et al.Mortality after hospitalisation for COPD.Chest,2002,121(5):1441.
  • 5Soler-Catalu a JJ,Martinez-Garcia MA,Román Sánchez P,et al.Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.Thorax,2005,60(11):925.
  • 6GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 7Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 8Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 9冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 10王红霞.小剂量阿奇霉素联合吸入性糖皮质激素治疗慢性阻塞性肺疾病[J].中国保健营养(下旬刊),2014,25(1):411.

共引文献8255

同被引文献43

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部